Press release
Neuroprotection Industry Trends Highlight Strong Growth to US$ 60.1 Billion by 2031 - Analysis by TMR
Neuroprotection Market Research Report
The global neuroprotection market was valued at US$ 31.6 billion in 2022 and is projected to grow at a CAGR of 7.5% from 2023 to 2031, reaching US$ 60.1 billion by the end of 2031. The market growth is driven by the rising prevalence of neurodegenerative disorders, increased investments in neurological research, and advancements in neuroprotective therapies, including novel drug development and regenerative medicine approaches.
Don't miss out on the latest market intelligence. Get your sample today@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40553
Market Overview:
The Neuroprotection Market is expanding rapidly, driven by an increasing prevalence of neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, as well as the rising demand for innovative therapeutic solutions. Neuroprotection refers to strategies and interventions aimed at preventing or slowing the progression of neuronal damage in the central nervous system (CNS). The market includes a broad range of products, including drugs, biologics, and devices, which focus on improving the survival and functionality of neurons.
Market Demand:
The increasing burden of neurodegenerative and neurological disorders, coupled with advancements in early diagnosis and therapeutic options, is driving robust demand. The growing interest in personalized medicine and targeted therapies is further propelling the neuroprotection market.
Market Description:
The neuroprotection market encompasses therapeutic and preventive measures designed to safeguard neural tissues from injury or degeneration caused by ischemia, trauma, or neurodegenerative diseases. Key areas of application include:
• Neurodegenerative Diseases: Addressing the progression of disorders such as Alzheimer's, Parkinson's, and Huntington's diseases.
• Acute Neurological Conditions: Treatment and prevention of stroke, traumatic brain injury, and spinal cord injury.
• Ophthalmic Disorders: Managing glaucoma and optic neuropathy with neuroprotective therapies.
This market is driven by a growing geriatric population, increasing awareness of CNS disorders, and advancements in drug development and biotechnology.
Market Key Players-
• Daiichi Sankyo Company
• Eli Lilly and Company
• AbbVie Inc.
• Dr. Reddy's Laboratories Ltd.
• Teva Pharmaceutical Industries Ltd.
• Novartis AG
• AstraZeneca plc.
• Astrocyte Pharmaceuticals, Inc.
• F. Hoffmann-La Roche AG
• Biogen Inc.
Recent Key Player Developments:
• Biogen (2024): Expanded its portfolio by acquiring a promising neuroprotective drug candidate targeting multiple sclerosis.
• Roche (2023): Initiated Phase III clinical trials for an innovative neuroprotective therapy aimed at early-stage Alzheimer's disease.
• AbbVie (2024): Announced a strategic partnership with a biotech startup specializing in neurotrophic factor-based therapies.
• Pfizer (2024): Expanded its neurology segment with the introduction of a novel neuroprotective agent for stroke recovery.
Discuss Implications for Your Industry Request Sample Research PDF@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40553
Growth Drivers:
1. Rising Prevalence of Neurodegenerative Disorders: An aging global population is contributing to an increased incidence of diseases like Alzheimer's and Parkinson's, which drives demand for neuroprotective therapies.
2. Innovative Drug Development: Progress in biologics, small molecules, and combination therapies for CNS disorders enhances market growth.
3. Increasing Investments in R&D: Governments and private organizations are heavily funding neuroscience research to develop effective neuroprotective solutions.
4. Emerging Therapies: Advancements in gene therapy, stem cell therapy, and neurotrophic factors are revolutionizing the neuroprotection landscape.
5. Growing Awareness of Mental Health: Rising awareness about neurological health and early diagnosis fuels the adoption of neuroprotective treatments.
Applications:
• Neurodegenerative Diseases: Alzheimer's, Parkinson's, Huntington's disease, and amyotrophic lateral sclerosis (ALS).
• Acute Neurological Conditions: Stroke, traumatic brain injuries, and spinal cord injuries.
• Ophthalmic Conditions: Glaucoma and retinal degenerative diseases.
• CNS Disorders: Epilepsy, multiple sclerosis, and neuropathic pain.
Segmentations:
1. By Product Type:
o Drugs
o Biologics
o Devices
2. By Indication:
o Alzheimer's Disease
o Parkinson's Disease
o Stroke
o Glaucoma
3. By End-User:
o Hospitals
o Clinics
o Research Institutes
o Pharmaceutical Companies
4. By Region:
o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East & Africa
To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/neuroprotection-market.html
Why Buy This Report:
• Comprehensive Market Insights: Gain a deep understanding of the neuroprotection market, including trends, challenges, and opportunities.
• Emerging Technologies and Therapies: Learn about the latest innovations and their impact on the neuroprotection landscape.
• Competitive Intelligence: Analyze strategies, product pipelines, and developments of key players.
• Strategic Decision-Making Support: Leverage market data and analysis to make informed business and investment decisions.
• Regional Market Analysis: Understand growth prospects and trends across key geographical regions.
This report serves as a valuable resource for pharmaceutical companies, biotechnology firms, healthcare providers, and investors aiming to understand the dynamics of the neuroprotection market and identify opportunities for growth and innovation.
More Trending Research Reports-
• Neuroprotection market - https://www.biospace.com/neuroprotection-market-to-reach-us-47-000-0-mn-by-2025-increasing-incidence-of-neurological-disorders-to-drive-the-market
• Anti-Infective Drugs Market Size Will Grow at a CAGR of 4.0% by 2031 - https://www.globenewswire.com/news-release/2024/10/08/2959725/32656/en/Anti-Infective-Drugs-Market-Size-Will-Grow-at-a-CAGR-of-4-0-by-2031-Surging-Demand-for-Antivirals-are-Boost-Market-Development-Transparency-Market-Research-Inc.html
About Us Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuroprotection Industry Trends Highlight Strong Growth to US$ 60.1 Billion by 2031 - Analysis by TMR here
News-ID: 3797127 • Views: …
More Releases from Transparency Market Research Pvt Ltd
Resistance Spot Welding Machines Market Expected to Expand at 5.9% CAGR, Reachin …
Resistance Spot Welding Machines Market Outlook 2034
The global resistance spot welding machines market was valued at US$ 3.4 Billion in 2023 and is expected to reach US$ 6.2 Billion by 2034, growing at a CAGR of 5.9% from 2024 to 2034. Rising demand from the automotive and manufacturing industries, where high-speed and reliable welding processes are essential, is fueling market growth. Technological advancements and increasing automation in production lines are…
Electrolyzer Market Size Forecast to USD 5.6 Billion by 2034 with a Focus on Gre …
Electrolyzer Market Outlook 2034
The global electrolyzer market was valued at US$ 509.9 Million in 2023 and is projected to reach US$ 5.6 Billion by 2034, growing at a remarkable CAGR of 24.5% from 2024 to 2034. Surging demand for green hydrogen as a clean energy source is a major driver of market growth. Supportive government policies, advancements in electrolyzer technologies, and the global push toward decarbonization are further accelerating the…
Global Demand for Functional and Fashionable Sportswear to Push Golf Apparel & S …
Golf Apparel and Shoes Market Outlook 2034
The global golf apparel & shoes market was valued at US$ 10.0 Billion in 2023 and is expected to reach US$ 16.7 Billion by 2034, growing at a CAGR of 4.9% from 2024 to 2034. Market growth is driven by the rising popularity of golf as both a recreational and professional sport, along with increasing participation rates globally. Innovation in performance-enhancing fabrics and footwear…
Rising Demand for Eco-friendly Menstrual Solutions to Propel Organic Period Care …
Organic Period Care Products Market Outlook 2034
The global organic period care products market was valued at US$ 2.6 Bn in 2023 and is projected to reach US$ 5.2 Bn by 2034, expanding at a CAGR of 6.6% from 2024 to 2034. Growth is fueled by rising consumer awareness about menstrual health, environmental sustainability, and the harmful effects of synthetic materials. Increasing preference for chemical-free, biodegradable, and skin-friendly products is driving…
More Releases for Neuroprotection
Breakthrough in Neuroprotection: Nooglutil Shows Promise in Preclinical Studies
A novel neuroprotective agent, Nooglutil [https://www.biofingredients.com/biof-supply-nooglutil-cas-112193-35-8-n-5-hydroxy-3-pyridinylcarbonyl-l-glutamic-acid-product/], has emerged as a promising candidate for treating neurodegenerative disorders, according to recent preclinical research. Developed to address unmet medical needs in Alzheimer's disease (AD), Parkinson's disease (PD), and stroke recovery, Nooglutil combines two active components-nopracitabine and gyltio clone-to enhance neuronal resilience and cognitive function through dual mechanisms.
Mechanism and Preclinical Efficacy
Nopracitabine, a natural neurotransmitter precursor, promotes acetylcholine synthesis, critical for memory and learning .…
Neuroprotection: A Guide to Understanding the Process
Neuroprotection is involvement capable to affect the etiology or the pathogenesis of the neurodegenerative diseases. They delay the onset or the development of neurodegenerative diseases. Neuroprotective products are medications that protect the brain neurons from deterioration and injury.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPMD00002291/?utm_source=OpenPR&utm_medium=10129
These products are used in the cure of several central nervous system complications such as Alzheimer's disease, Parkinson's disease and traumatic brain injuries…
Empowering Neuroprotection: Market Growth Projections & Trends 2024-2031
Report Overview
Neuroprotection Market is expected to grow at a CAGR of 8.2% during the forecast period 2024-2031
Neuroprotection refers to the capacity to promote recovery, salvage, and regeneration of the nervous system's structure, cells, and functions. It involves the prevention of neuronal cell death by inhibiting pathogenic cascades that lead to cellular dysfunction.
Various neurochemical modulators can cause damage to the nervous system, highlighting the importance of therapeutic…
Neuroprotective Agents Market - Empowering Neuroprotection for Optimal Brain Fun …
Newark, New Castle, USA: The "Neuroprotective Agents Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Neuroprotective Agents Market: https://www.growthplusreports.com/report/neuroprotective-agents-market/8412
This latest report researches the industry structure, sales, revenue,…
Neuroprotection Market Share, Sales Channels and Overview Till 2028
Neuroprotection is involvement capable to affect the etiology or the pathogenesis of the neurodegenerative diseases. They delay the onset or the development of neurodegenerative diseases. Neuroprotective products are medications that protect the brain neurons from deterioration and injury. These products are used in the cure of several central nervous system complications such as Alzheimer's disease, Parkinson's disease and traumatic brain injuries among others. Neuroprotective agents in clinical pipelines comprise small-molecule…
Global Neuroprotection Market Research
The Global Neuroprotection Market Research Global Neuroprotection Market Research neuroprotection showcase was esteemed at roughly US$ 47,000.0 Mn in 2016 is anticipated to enroll a development rate of 8.2% from 2017 to 2025, as per another report distributed by Transparency Market Research (TMR) titled "Neuroprotection Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017– 2025". The Global Neuroprotection Market Research report proposes that expanding occurrence and predominance…
